+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

U.S. Esoteric Testing Market - Industry Outlook & Forecast 2021-2026

  • PDF Icon


  • June 2021
  • Region: United States
  • Arizton
  • ID: 5336106
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this U.S. Esoteric Testing Market Report

The U.S. esoteric testing market size is expected to grow at a CAGR of around 7% during 2020-2026

Advancement in technology such as first-generation genome sequencing and next-generation genome sequencing drives the U.S. esoteric testing market growth. The increasing usage of precision medicines and personalized medicines is booming in the clinical diagnostics and esoteric testing market in the US. The out-patient testing segment occupies 78% of the U.S. esoteric testing market share. During the COVID-19 pandemic, this testing played a significant role in analyzing the structure of the virus, assigning the treatment for infection, and detecting the presence in infected people. Thus, the advent of COVID-19 is positively impacting the demand for esoteric testing across the country.

The following factors are likely to contribute to the growth of the US esoteric testing market during the forecast period:
  • Paradigm shift from diagnosis & treatment to risk assessment and predisposition
  • Increasing trends of technological advancements
  • Rising growth towards personalized medication/precision medicine
  • Automation of laboratory testing

The report considers the present scenario of the U.S. esoteric testing market and its market dynamics for the period 2020-2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.


The U.S. esoteric testing market research report includes a detailed segmentation by field of study, technology, patient type. There are more than 31 companion diagnostics assays in the market today, and LabCorp and Covance have helped in the development of almost 75% of those. The largest application area of such tests is Oncology. Quest Diagnostics provides a wide range of mass spectrometry innovations such as liquid chromatography-tandem mass spectrometry assays, insulin-like growth factor, thyroglobulin, and steroid multiplexing. Quest diagnostics have innovated the MS to produce a method to detect the IGF-I factor, which produces rapid and more accurate results.

Based on technology, esoteric tests are helpful in the diagnosis of many rare disorders. The next-generation sequencing technique is a modern technique of gene sequencing, which is a highly efficient and rapid method of gene sequencing. Esoteric laboratories were the first to adopt the LC-MS/MS technology as it provided the advantage of being cost-effective over conventional testing methods such as HPLC and GC-MS. Technological advancements in gene sequencing have been continuously reduced the cost required and the time taken for genome sequencing. LC-MS/MS to witness enormous growth for high application in laboratory diagnostics. Quest Diagnostic is one of the leading vendors in the US esoteric testing market and clinical diagnostics market and uses LC-MS/MS technology for testing in endocrinology.

Out-patient care is widely accepted by patients who are opting the genetic testing. The vendors providing out-patient testing services first confirm the billing ability of the patient to pay for the test. Out-patient testing is witnessing growth in revenue, as the esoteric test in an inpatient setting is not economical for most hospitals. Most of the hospitals focus on making the tests in an out-patient setting.

Segmentation by Field of Study
  • Endocrinology
  • Genetics
  • Immunology
  • Infectious Disease
  • Oncology
  • Others

Segmentation by Technology
  • Immunoassay
  • LC-MS/MS
  • RT-PCR
  • Flow Cytometry
  • Gene Sequencing
  • Others

Segmentation by Patient Type
  • Inpatient Testing
  • Outpatient Testing


Technology advancement and collaboration are the key factors driving the competition in the US market. Players are looking to equip their testing catalog with the latest findings and advanced technologies. Laboratory Corporation of America Holdings has performed many acquisitions over the years, which has strengthened its position in the market. It has helped in strengthening the company’s scientific capabilities and increasing the therapeutic fields. In the diagnostics segment, a significant part of the company’s revenue is generated in the US and focusing on improving its presence across the globe.

Major Vendors
  • Laboratory Corporation of America Holdings (Labcorp)
  • Business Overview
  • Products Offerings
  • Key Strategies
  • Key Strengths
  • Key Opportunities
  • Quest Diagnostics
  • BioReference Laboratories
  • Eurofins Scientific
  • Mayo Clinic Laboratories
  • Sonic Healthcare

Other Prominent Vendors
  • Myriad Genetics
  • Business Overview
  • Product Offerings
  • ARUP Laboratories
  • South Bend Medical Foundation
  • Capstone Healthcare
  • BioAgilytix
  • Biological Laboratory

1. What is the U.S. esoteric testing market size?
2. What is the growth rate of the United States esoteric testing market?
3. Who are the key players in the esoteric testing market?
4. What are the upcoming trends in the esoteric testing market?
5. Which technology segment dominated the esoteric testing industry in 2020?
Frequently Asked Questions about the U.S. Esoteric Testing Market

What is the estimated value of the U.S. Esoteric Testing Market?

The U.S. Esoteric Testing Market was estimated to be valued at $5.48 Billion in 2020.

What is the growth rate of the U.S. Esoteric Testing Market?

The growth rate of the U.S. Esoteric Testing Market is 6.5%, with an estimated value of $8.01 Billion by 2026.

What is the forecasted size of the U.S. Esoteric Testing Market?

The U.S. Esoteric Testing Market is estimated to be worth $8.01 Billion by 2026.

Who are the key companies in the U.S. Esoteric Testing Market?

Key companies in the U.S. Esoteric Testing Market include Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics, BioReference Laboratories, Eurofins Scientific, Mayo Clinic Laboratories, Sonic Healthcare, Myriad Genetics, ARUP Laboratories, South Bend Medical Foundation and Capstone Healthcare.

Table of Contents

1 Research Methodology2 Research Objectives3 Research Process
4 Scope & Coverage
4.1 Market Definition
4.1.1 Inclusions
4.1.2 Exclusions
4.1.3 Market Estimation Caveats
4.2 Base Year
4.3 Scope of the Study
4.3.1 Market Segmentation by Field of Study
4.3.2 Market Segmentation by Technology
4.3.3 Market Segmentation by Patient Type
4.3.4 Market Segmentation by Geography
5 Report Assumptions & Caveats
5.1 Key Caveats
5.2 Currency Conversion
5.3 Market Derivation
6 Market at a Glance
7 Introduction
7.1 Overview
7.2 Esoteric Testing in COVID-19
8 Market Opportunities & Trends
8.1 Automation of Laboratory Testing
8.2 Growing Use of Companion Diagnostics for Therapy Selection
8.3 Increasing Use of Genetic Counseling
9 Market Growth Enablers
9.1 Inclination Toward Personalized Medicine
9.2 Increasing Focus on Risk Assessment & Predisposition
9.3 Growing Technological Advancements
10 Market Growth Restraints
10.1 Less Performed Tests & High Cost
10.2 Social, Legal, & Ethical Implications of Genetic Testing
11 Market Landscape
11.1 Market Overview
11.2 Market Size & Forecast
11.3 Five Forces Analysis
11.3.1 Threat of New Entrants
11.3.2 Bargaining Power of Suppliers
11.3.3 Bargaining Power of Buyers
11.3.4 Threat of Substitutes
11.3.5 Competitive Rivalry
12 Field of Study
12.1 Market Snapshot & Growth Engine
12.2 Market Overview
12.3 Genetics
12.3.1 Market Overview
12.3.2 Market Size & Forecast
12.4 Immunology
12.4.1 Market Overview
12.4.2 Market Size & Forecast
12.5 Oncology
12.5.1 Market Overview
12.5.2 Market Size & Forecast
12.6 Infectious Diseases
12.6.1 Market Overview
12.6.2 Market Size & Forecast
12.7 Endocrinology
12.7.1 Market Overview
12.7.2 Market Size & Forecast
12.8 Others
12.8.1 Market Overview
12.8.2 Market Size & Forecast
13 Technology
13.1 Market Snapshot & Growth Engine
13.2 Market Overview
13.3 Immunoassay
13.3.1 Market Overview
13.3.2 Market Size & Forecast
13.4 RT-PCR
13.4.1 Market Overview
13.4.2 Market Size & Forecast
13.5 LC-MS/MS
13.5.1 Market Overview
13.5.2 Market Size & Forecast
13.6 Flow Cytometry
13.6.1 Market Overview
13.6.2 Market Size & Forecast
13.7 Gene Sequencing
13.7.1 Market Overview
13.7.2 Market Size & Forecast
13.8 Others
13.8.1 Market Overview
13.8.2 Market Size & Forecast
14 Patient Type
14.1 Market Snapshot & Growth Engine
14.2 Market Overview
14.3 Inpatient Testing
14.3.1 Market Overview
14.3.2 Market Size & Forecast
14.4 Outpatient Testing
14.4.1 Market Overview
14.4.2 Market Size & Forecast
15 Competitive Landscape
15.1 Competition Overview
15.2 Market Share Analysis
15.2.1 Labcorp
15.2.2 Quest Diagnostics
16 Key Company Profiles
16.1 Laboratory Corporation of America Holdings
16.1.1 Business Overview
16.1.2 Laboratory Corporation of America Holdings in Esoteric Testing Market
16.1.3 Product Offerings
16.1.4 Key Strategies
16.1.5 Key Strengths
16.1.6 Key Opportunities
16.2 Quest Diagnostics Incorporated
16.2.1 Business Overview
16.2.2 Quest Diagnostics in Esoteric Testing Market
16.2.3 Service Offerings
16.2.4 Key Strategies
16.2.5 Key Strengths
16.2.6 Key Opportunities
16.3 BioReference Laboratories
16.3.1 Business Overview
16.3.2 BioReference Laboratories in Esoteric Testing Market
16.3.3 Product Offerings
16.3.4 Key Strategies
16.3.5 Key Strengths
16.3.6 Key Opportunities
16.4 Eurofins Scientific
16.4.1 Business Overview
16.4.2 Eurofins Scientific in Esoteric Testing Market
16.4.3 Service Offerings
16.4.4 Key Strategies
16.4.5 Key Strengths
16.4.6 Key Opportunities
16.5 Mayo Clinic Laboratories
16.5.1 Business Overview
16.5.2 Mayo Clinic Laboratories in Esoteric Testing Market
16.5.3 Service Offerings
16.5.4 Key Strategies
16.5.5 Key Strengths
16.5.6 Key Opportunities
16.6 Sonic Healthcare Limited
16.6.1 Business Overview
16.6.2 Sonic Healthcare in Esoteric Testing Market
16.6.3 Service Offerings
16.6.4 Key Strategies
16.6.5 Key Strengths
16.6.6 Key Opportunities
17 Other Prominent Vendors
17.1 Myriad Genetics, Inc.
17.1.1 Business Overview
17.1.2 Service Offerings
17.2 Arup Laboratories
17.2.1 Business Overview
17.2.2 Service Offerings
17.3 South Bend Medical Foundation
17.3.1 Business Overview
17.3.2 Service Offerings
17.4 Capstone Healthcare, LLC
17.4.1 Business Overview
17.4.2 Service Offerings
17.5 Bioagilytix Labs
17.5.1 Business Overview
17.5.2 Service Offerings
17.6 Biological Laboratory, Inc.
17.6.1 Business Overview
17.6.2 Service Offerings
18 Report Summary
18.1 Key Takeaways
18.2 Strategic Recommendations
19 Quantitative Summary
19.1 Market by Field of Study
19.2 Market by Technology
19.3 Market by Patient Type
20 Appendix
20.1 Abbreviations

Companies Mentioned

  • Laboratory Corporation of America Holdings (Labcorp)
  • Quest Diagnostics
  • BioReference Laboratories
  • Eurofins Scientific
  • Mayo Clinic Laboratories
  • Sonic Healthcare
  • Myriad Genetics
  • ARUP Laboratories
  • South Bend Medical Foundation
  • Capstone Healthcare
  • BioAgilytix
  • Biological Laboratory


Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.

Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.